Activation of TAL1 characterizes up to 60% of cases of human T cell acute lymphoblastic leukemia, making it the most frequent gain-of-function mutation observed in this disorder. TAL1 (also designated SCL) is a serine phosphoprotein and basic helix-loop-
Concentration:
0.2 mg/mL
Buffer:
PBS, 0.05% BSA, 0.05% azide
Source:
Animal
* VAT and and shipping costs not included. Errors and price changes excepted
